These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 476367)

  • 21. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
    McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
    J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sertraline in social phobia.
    Van Ameringen M; Mancini C; Streiner D
    J Affect Disord; 1994 Jun; 31(2):141-5. PubMed ID: 8071477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.
    Sethna ER
    Br J Psychiatry; 1974 Mar; 124(0):265-72. PubMed ID: 4599813
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenelzine and atenolol in social phobia.
    Liebowitz MR; Schneier F; Campeas R; Gorman J; Fyer A; Hollander E; Hatterer J; Papp L
    Psychopharmacol Bull; 1990; 26(1):123-5. PubMed ID: 2196620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses to phenelzine and amitriptyline absence of differential predictors by multiple regression analysis.
    Bhat AV; Rowan PR; Paykel ES
    J Affect Disord; 1984 Apr; 6(2):209-18. PubMed ID: 6233353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of phenelzine in continuation therapy.
    Davidson J; Raft D
    Neuropsychobiology; 1984; 11(3):191-4. PubMed ID: 6433222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenelzine and exposure in the treatment of phobias.
    Solyom C; Solyom L; LaPierre Y; Pecknold J; Morton L
    Biol Psychiatry; 1981 Mar; 16(3):239-47. PubMed ID: 6112024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-sex differences in response to antidepressant drugs.
    Raskin A
    J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.